Skip to content

Drug interactions

Dexlansoprazole + Infigratinib

Severity: Major

Dexlansoprazole and Infigratinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Infigratinib has pH-dependent solubility, so reduced gastric acidity lowers its absorption. Dexlansoprazole may decrease infigratinib exposure and weaken its anticancer effect.

What this interaction means in plain words

Dexlansoprazole and Infigratinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Increased gastric pH reduces infigratinib solubility and absorption.

What to do

Avoid PPIs with infigratinib. If acid reduction is required, use a locally acting antacid separated from infigratinib by the interval stated in the labeling.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexlansoprazole and Infigratinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dexlansoprazole with Infigratinib?

MediHelp rates the interaction as major. Dexlansoprazole and Infigratinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Infigratinib has pH-dependent solubility, so reduced gastric acidity lowers its absorption. Dexlansoprazole may decrease infigratinib exposure and weaken its anticancer effect.

How serious is the interaction between Dexlansoprazole and Infigratinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid PPIs with infigratinib. If acid reduction is required, use a locally acting antacid separated from infigratinib by the interval stated in the labeling.

What other medicines interact with Dexlansoprazole?

MediHelp also lists interactions of Dexlansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Dexlansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in